Inhibitory Effects of Rabdosia rubescens in Esophageal Squamous Cell Carcinoma: Network Pharmacology and Experimental Validation

Figure 8

Molecular docking results of key targets and bioactive molecules. (a) AURKA-sideritiflavone. (b) CCNA2-rubiadin. (c) CCNB2-sideritiflavone. (d) TTK-rubiadin. (e) TOP2A-rubiadin. (f) CHEK1-rubiadin. (g) MELK-sideritiflavone.

(a)

(b)

(c)

(d)

(e)

(f)

(g)